Brainstorm Cell Therapeutics Inc. - Common Stock (BCLI)
1.8200
-0.0900 (-4.71%)
Brainstorm Cell Therapeutics is a biotechnology company focused on developing innovative therapies aimed at treating neurodegenerative diseases and neurological conditions through the harnessing of stem cell technology
The company is particularly known for its research and development of treatments using its proprietary approach to generating cells that can potentially repair or regenerate damaged tissues in the central nervous system. By leveraging its expertise in cellular therapy, Brainstorm Cell aims to provide new hope for patients suffering from debilitating disorders. Through ongoing clinical trials and research initiatives, the company is committed to advancing its scientific discoveries into effective treatment options.
Frequently Asked Questions
Is Brainstorm Cell Therapeutics Inc. - Common Stock publicly traded?
Yes, Brainstorm Cell Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Brainstorm Cell Therapeutics Inc. - Common Stock trade on?
Brainstorm Cell Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Brainstorm Cell Therapeutics Inc. - Common Stock?
The ticker symbol for Brainstorm Cell Therapeutics Inc. - Common Stock is BCLI on the Nasdaq Stock Market
What is the current price of Brainstorm Cell Therapeutics Inc. - Common Stock?
The current price of Brainstorm Cell Therapeutics Inc. - Common Stock is 1.820
When was Brainstorm Cell Therapeutics Inc. - Common Stock last traded?
The last trade of Brainstorm Cell Therapeutics Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Brainstorm Cell Therapeutics Inc. - Common Stock?
The market capitalization of Brainstorm Cell Therapeutics Inc. - Common Stock is 10.38M
How many shares of Brainstorm Cell Therapeutics Inc. - Common Stock are outstanding?
Brainstorm Cell Therapeutics Inc. - Common Stock has 5.70M shares outstanding.